IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Study of Reslizumab in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils
This study is ongoing, but not recruiting participants.
Sponsor:
Teva Branded Pharmaceutical Products, R&D Inc.
Collaborator:
PPD
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )
ClinicalTrials.gov Identifier:
NCT02452190
First received: May 13, 2015
Last updated: December 1, 2016
Last verified: December 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2018 |
| Estimated Primary Completion Date: | December 2017 (Final data collection date for primary outcome measure) |